SAN DIEGO – ResMed Director Peter Farrell on Aug. 1 sold 25,000 shares of stock at an average price of $49.04 for a total transaction of about $1.23 million. Farrell now owns 279,990 shares valued at about $13.73 million. Also on Aug.
SAN DIEGO – Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares of company stock on the open market in a transaction dated May 1. The stock was sold at $49.80 for a total value of $1.245 million.
POWAY, Calif. – Michael “Mick” Farrell, president of ResMed’s Americas division since 2011, will replace his father, Peter Farrell, as CEO and be appointed to the company’s board effective March 1, according to a press release.
SAN DIEGO – ResMed is on track to choose an internal candidate as its next CEO in early 2013, The Australian has reported. The two candidates vying for the position: Michael Farrell, president of Americas; and Robert Douglas, COO.
SAN DIEGO – ResMed this week reported revenue of $339.7 million for the quarter ended Sept. 30, 2012, an 8% increase over the same quarter last year. Net income was $71.3 million, a 41% increase; and earnings per share were $0.49, a 48% increase.